Another recent preclinical study found that the combination of NANOG inhibition and radiotherapy produced an additive effect with a decrease in cell viability, stemness properties, and radiotherapy resistance of CD44+ HNSCC cells [76]. Here, CD44 is linked to head and neck squamous cell carcinoma.